Impact of the COVID-19 related border restrictions on influenza and other common respiratory viral infections in New Zealand.

ABSTRACT:

Background

New Zealand's (NZ) complete absence of community transmission of influenza and respiratory syncytial virus (RSV) after May 2020, likely due to COVID-19 elimination measures, provided a rare opportunity to assess the impact of border restrictions on common respiratory viral infections over the ensuing 2 years.

Methods

We collected the data from multiple surveillance systems, including hospital-based severe acute respiratory infection surveillance, SHIVERS-II, -III and -IV community cohorts for acute respiratory infection (ARI) surveillance, HealthStat sentinel general practice (GP) based influenza-like illness surveillance and SHIVERS-V sentinel GP-based ARI surveillance, SHIVERS-V traveller ARI surveillance and laboratory-based surveillance. We described the data

SUBMITTER: Huang QS 

PROVIDER: S-EPMC10864123 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature